Vallari Shah

London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications

Safety, tolerability, and pharmacokinetics of lisaftoclax (APG-2575)-based therapy in patients with chronic lymphocytic leukemia: Phase 1b/2 study.

Safety, tolerability, and pharmacokinetics of lisaftoclax (APG-2575)-based therapy in patients with chronic lymphocytic leukemia: Phase 1b/2 study.

Journal: Med (New York, N.Y.)
Published: April 16, 2025

Risk of COVID-19 death in cancer patients: an analysis from Guy's Cancer Centre and King's College Hospital in London.

Risk of COVID-19 death in cancer patients: an analysis from Guy's Cancer Centre and King's College Hospital in London.

Journal: British journal of cancer
Published: January 14, 2021

Solitary Conjunctivocorneal Plasmacytoma Arising After Cataract Surgery.

Solitary Conjunctivocorneal Plasmacytoma Arising After Cataract Surgery.

Journal: Cornea
Published: September 02, 2020

Poor outcome and prolonged persistence of SARS-CoV-2 RNA in COVID-19 patients with haematological malignancies; King's College Hospital experience.

Poor outcome and prolonged persistence of SARS-CoV-2 RNA in COVID-19 patients with haematological malignancies; King's College Hospital experience.

Journal: British journal of haematology
Published: June 12, 2020

Predicting ultrahigh risk multiple myeloma by molecular profiling: an analysis of newly diagnosed transplant eligible myeloma XI trial patients.

Predicting ultrahigh risk multiple myeloma by molecular profiling: an analysis of newly diagnosed transplant eligible myeloma XI trial patients.

Journal: Leukemia
Published: October 11, 2019

The relative importance of factors predicting outcome for myeloma patients at different ages: results from 3894 patients in the Myeloma XI trial.

The relative importance of factors predicting outcome for myeloma patients at different ages: results from 3894 patients in the Myeloma XI trial.

Journal: Leukemia
Published: April 01, 2019

A clinical prediction model for outcome and therapy delivery in transplant-ineligible patients with myeloma (UK Myeloma Research Alliance Risk Profile): a development and validation study.

A clinical prediction model for outcome and therapy delivery in transplant-ineligible patients with myeloma (UK Myeloma Research Alliance Risk Profile): a development and validation study.

Journal: The Lancet. Haematology
Published: September 30, 2018

Subclonal TP53 copy number is associated with prognosis in multiple myeloma.

Subclonal TP53 copy number is associated with prognosis in multiple myeloma.

Journal: Blood
Published: June 12, 2018

Constitutional mutation in CDKN2A is associated with long term survivorship in multiple myeloma: a case report.

Constitutional mutation in CDKN2A is associated with long term survivorship in multiple myeloma: a case report.

Journal: BMC cancer
Published: June 27, 2017

Apparent diffusion coefficient of vertebral haemangiomas allows differentiation from malignant focal deposits in whole-body diffusion-weighted MRI.

Apparent diffusion coefficient of vertebral haemangiomas allows differentiation from malignant focal deposits in whole-body diffusion-weighted MRI.

Journal: European radiology
Published: May 25, 2017

Antagonistic human FcγRIIB (CD32B) antibodies have anti-tumor activity and overcome resistance to antibody therapy in vivo.

Antagonistic human FcγRIIB (CD32B) antibodies have anti-tumor activity and overcome resistance to antibody therapy in vivo.

Journal: Cancer cell
Published: June 27, 2014

Inhibitory FcγRIIb (CD32b) becomes activated by therapeutic mAb in both cis and trans and drives internalization according to antibody specificity.

Inhibitory FcγRIIb (CD32b) becomes activated by therapeutic mAb in both cis and trans and drives internalization according to antibody specificity.

Journal: Blood
Published: November 15, 2013
Showing 1-12 of 13

Last Updated: 09/26/2026